| 发明名称 |
NK1 Antagonists |
| 摘要 |
A compound having the general structure shown in Formula I: or pharmaceutically acceptable salts and/or solvates thereof are useful in treating diseases or conditions mediated by NK1 receptors, for example various physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough. |
| 申请公布号 |
US2012295879(A1) |
申请公布日期 |
2012.11.22 |
| 申请号 |
US201113245403 |
申请日期 |
2011.09.26 |
| 申请人 |
PALANI ANANDAN;HUANG XIANHAI;XIAO DONG;SHAH SAPNA S.;PALIWAL SUNIL;TSUI HON-CHUNG;WROBLESKI MICHELLE LACI;RAO ASHWIN U.;WANG CHENG;SHIH NENG-YANG;OPKO HEALTH, INC. |
发明人 |
PALANI ANANDAN;HUANG XIANHAI;XIAO DONG;SHAH SAPNA S.;PALIWAL SUNIL;TSUI HON-CHUNG;WROBLESKI MICHELLE LACI;RAO ASHWIN U.;WANG CHENG;SHIH NENG-YANG |
| 分类号 |
A61K31/454;A61K31/451;A61K31/4523;A61K31/4545;A61K31/56;A61K31/573;A61P1/18;A61P11/14;A61P25/22;A61P25/24 |
主分类号 |
A61K31/454 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
